Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Defibrillator implantation early after myocardial infarction.

Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J; IRIS Investigators.

N Engl J Med. 2009 Oct 8;361(15):1427-36. doi: 10.1056/NEJMoa0901889.

2.

Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies.

Wienbergen H, Gitt AK, Schiele R, Juenger C, Heer T, Meisenzahl C, Limbourg P, Bossaller C, Senges J; MITRA PLUS Study Group.

Am J Cardiol. 2003 Aug 1;92(3):285-8.

PMID:
12888133
3.

Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction.

Wienbergen H, Schiele R, Gitt AK, Juenger C, Heer T, Meisenzahl C, Landgraf H, Bossaller C, Senges J; MITRA PLUS Study Group.

Am J Cardiol. 2002 Nov 15;90(10):1045-9.

PMID:
12423701
4.
5.
6.

Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry.

Zahn R, Schiele R, Schneider S, Gitt AK, Seidl K, Bossaller C, Schuler G, Gottwik M, Altmann E, Rosahl W, Senges J.

Am J Cardiol. 2001 Jan 1;87(1):1-6.

PMID:
11137824
8.

Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors.

Brodde OE, Adamczyk M, Busch F, Bossaller C, Duske E, Fleck E, Götze S, Auch-Schwelk W.

J Am Coll Cardiol. 1995 Mar 1;25(3):761-7.

9.

Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction.

Götze S, Auch-Schwelk W, Bossaller C, Thelen J, Fleck E.

Transpl Int. 1994 May;7(3):157-62.

PMID:
8060463
10.

Effect of cyclosporin on kidney proteolytic enzymes in men and rats.

Olbricht CJ, Steinker M, Auch-Schwelk W, Bossaller C, Haas J, Koch KM.

Nephrol Dial Transplant. 1994;9(1):22-6.

PMID:
8177472
11.

Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.

Auch-Schwelk W, Kuchenbuch C, Claus M, Walther B, Bossaller C, Friedel N, Graf K, Gräfe M, Fleck E.

Eur Heart J. 1993 Nov;14 Suppl I:154-60.

PMID:
8293767
12.

Calcium entry blockade may prevent cyclosporin A-induced hypersensitivity to angiotensin II and endothelial dysfunction in the rat aorta.

Götze S, Auch-Schwelk W, Bossaller C, Thelen J, Fleck E.

Eur Heart J. 1993 Nov;14 Suppl I:104-10.

PMID:
8293761
13.

Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells.

Graf K, Gräfe M, Bossaller C, Niehus J, Schulz KD, Auch-Schwelk W, Fleck E.

Eur J Clin Chem Clin Biochem. 1993 May;31(5):267-72.

PMID:
8395230
14.

Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells.

Gräfe M, Bossaller C, Graf K, Auch-Schwelk W, Baumgarten CR, Hildebrandt A, Fleck E.

Am J Physiol. 1993 May;264(5 Pt 2):H1493-7.

PMID:
8388656
15.

Endothelial and vascular smooth muscle function after chronic treatment with cyclosporin A.

Auch-Schwelk W, Bossaller C, Götze S, Thelen J, Fleck E.

J Cardiovasc Pharmacol. 1993 Mar;21(3):435-40.

PMID:
7681505
16.

ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.

Auch-Schwelk W, Bossaller C, Claus M, Graf K, Gräfe M, Fleck E.

Cardiovasc Res. 1993 Feb;27(2):312-7.

PMID:
8386065
17.

In vivo measurement of endothelium-dependent vasodilation with substance P in man.

Bossaller C, Reither K, Hehlert-Friedrich C, Auch-Schwelk W, Graf K, Gräfe M, Fleck E.

Herz. 1992 Oct;17(5):284-90. Review.

PMID:
1282120
18.

Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.

Bossaller C, Auch-Schwelk W, Gräfe M, Graf K, Baumgarten C, Fleck E.

Agents Actions Suppl. 1992;38 ( Pt 3):171-7.

PMID:
1334349
19.

Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin-converting enzyme inhibitor enalapril.

Bossaller C, Auch-Schwelk W, Weber F, Götze S, Gräfe M, Graf K, Fleck E.

J Cardiovasc Pharmacol. 1992;20 Suppl 9:S91-5.

PMID:
1282636
20.

Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.

Auch-Schwelk W, Bossaller C, Claus M, Graf K, Gräfe M, Fleck E.

J Cardiovasc Pharmacol. 1992;20 Suppl 9:S62-7.

PMID:
1282632
Items per page

Supplemental Content

Loading ...
Write to the Help Desk